chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nystagmus, Pain, Pyrexia, Sinusitis, Tenderness
Clinical narrative: Fever of 102; chills; Body aches; Vomiting; Sick also, almost like sinus infection; Vestibular neuritis; Nystagmus on both eyes that makes her very dizzy.; joint pain; whole body was sore; severe headaches on and off; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off), DIZZINESS (dizziness) and PYREXIA (Fever of 102) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off) and DIZZINESS (dizziness). On 25-Feb-2021, the patient experienced PYREXIA (Fever of 102), CHILLS (chills), PAIN (Body aches), VOMITING (Vomiting), SINUSITIS (Sick also, almost like sinus infection), NEURITIS (Vestibular neuritis) and NYSTAGMUS (Nystagmus on both eyes that makes her very dizzy.). At the time of the report, ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off), DIZZINESS (dizziness), PYREXIA (Fever of 102), CHILLS (chills), PAIN (Body aches), VOMITING (Vomiting), SINUSITIS (Sick also, almost like sinus infection), NEURITIS (Vestibular neuritis) and NYSTAGMUS (Nystagmus on both eyes that makes her very dizzy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever of 102; chills; Body aches; Vomiting; Sick also, almost like sinus infection; Vestibular neuritis; Nystagmus on both eyes that makes her very dizzy.; joint pain; whole body was sore; severe headaches on and off; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off), DIZZINESS (dizziness) and PYREXIA (Fever of 102) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off) and DIZZINESS (dizziness). On 25-Feb-2021, the patient experienced PYREXIA (Fever of 102), CHILLS (chills), PAIN (Body aches), VOMITING (Vomiting), SINUSITIS (Sick also, almost like sinus infection), NEURITIS (Vestibular neuritis) and NYSTAGMUS (Nystagmus on both eyes that makes her very dizzy.). At the time of the report, ARTHRALGIA (joint pain), TENDERNESS (whole body was sore), HEADACHE (severe headaches on and off), DIZZINESS (dizziness), PYREXIA (Fever of 102), CHILLS (chills), PAIN (Body aches), VOMITING (Vomiting), SINUSITIS (Sick also, almost like sinus infection), NEURITIS (Vestibular neuritis) and NYSTAGMUS (Nystagmus on both eyes that makes her very dizzy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported. No treatment medications were not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Pyrexia
Clinical narrative: joints hurts a lot; slight fever, 100F; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), ARTHRALGIA (joints hurts a lot) and PYREXIA (slight fever, 100F) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced CHILLS (chills). On an unknown date, the patient experienced ARTHRALGIA (joints hurts a lot) and PYREXIA (slight fever, 100F). At the time of the report, CHILLS (chills), ARTHRALGIA (joints hurts a lot) and PYREXIA (slight fever, 100F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm/ arm soreness pain increased), HEADACHE (headache), PYREXIA (increasing fever) and VACCINATION SITE SWELLING (bumps appearing on his body that come and go away) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PYREXIA (increasing fever). On 02-Feb-2021, the patient experienced VACCINATION SITE SWELLING (bumps appearing on his body that come and go away). On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm/ arm soreness pain increased) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL FORTE) from 01-Feb-2021 to 02-Feb-2021 for Fever, at a dose of 1 dosage form. On 02-Feb-2021, PYREXIA (increasing fever) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in the arm/ arm soreness pain increased), HEADACHE (headache) and VACCINATION SITE SWELLING (bumps appearing on his body that come and go away) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Pyrexia: High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Nerve injury, Vaccination site erythema
Clinical narrative: nerve damage at the elbow and index; elbow pain; redness at the upper arm; numbness in fingers; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NERVE INJURY (nerve damage at the elbow and index), ARTHRALGIA (elbow pain), VACCINATION SITE ERYTHEMA (redness at the upper arm) and HYPOAESTHESIA (numbness in fingers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVE INJURY (nerve damage at the elbow and index), ARTHRALGIA (elbow pain), VACCINATION SITE ERYTHEMA (redness at the upper arm) and HYPOAESTHESIA (numbness in fingers). At the time of the report, NERVE INJURY (nerve damage at the elbow and index) and ARTHRALGIA (elbow pain) had not resolved and VACCINATION SITE ERYTHEMA (redness at the upper arm) and HYPOAESTHESIA (numbness in fingers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications was not provided. Treatment medications included bengay cream ,Naprosyn for relief of pain,800mg motrin, gabapentin 300mg 2 caps BID, steroid, nerve blocker. Lab test EMG test has been scheduled for 07 Apr 2021.  Based on the current information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Further information requested.; Sender's Comments: Based on the current information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Further information requested.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Decreased appetite, Erythema, Gastrooesophageal reflux disease, Headache
Clinical narrative: hives all over body (mentioned back, under breasts and arms); Red itchy burning patches on her body; acid reflux; headache; breast pain; no appetite; Red itchy burning patches on her body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA, BREAST PAIN, DECREASED APPETITE, ERYTHEMA, and PRURITUS in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 03A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Parkinson's disease.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced BREAST PAIN, DECREASED APPETITE, ERYTHEMA, GASTROOESOPHAGEAL REFLUX DISEASE, and HEADACHE. On an unknown date, the patient experienced URTICARIA and PRURITUS. The patient was treated with TYLENOL at a dose of 1 dosage form BENADRYL at a dose of 1 dosage form. At the time of the report, URTICARIA, BREAST PAIN, DECREASED APPETITE, ERYTHEMA, PRURITUS, GASTROOESOPHAGEAL REFLUX DISEASE, and HEADACHE had resolved.            Treatment was taken along with concomitant medication by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: outcome of the event has been updated.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: hives all over body (mentioned back, under breasts and arms); Red itchy burning patches on her body; acid reflux; headache; breast pain; no appetite; Red itchy burning patches on her body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA, BREAST PAIN, DECREASED APPETITE, ERYTHEMA, and PRURITUS in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 03A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Parkinson's disease.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced BREAST PAIN, DECREASED APPETITE, ERYTHEMA, GASTROOESOPHAGEAL REFLUX DISEASE, and HEADACHE. On an unknown date, the patient experienced URTICARIA and PRURITUS. The patient was treated with TYLENOL at a dose of 1 dosage form BENADRYL at a dose of 1 dosage form. At the time of the report, URTICARIA, BREAST PAIN, DECREASED APPETITE, ERYTHEMA, PRURITUS, GASTROOESOPHAGEAL REFLUX DISEASE, and HEADACHE had resolved.            Treatment was taken along with concomitant medication by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: outcome of the event has been updated.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cancer.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   No treatment medication reported Case is crosslinked to MOD21-068315 and MOD21-068279
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Nasal obstruction, Secretion discharge, Sneezing
Clinical narrative: Sneezes; Cough; Mucus; Nostrils get plugged; Hard to breath at Night; Mild pain on injection site; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Cholesterol and Enlarged prostate. Concomitant products included ATORVASTATIN for Hyperlipidemia, AMLODIPINE for Hypertension.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Mild pain on injection site). On 19-Mar-2021, the patient experienced SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night). On 10-Mar-2021, VACCINATION SITE PAIN (Mild pain on injection site) had resolved. At the time of the report, SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included two prostate medications. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Telephone contact report received on 28-JUN-2021:Contain non significant information
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sneezes; Cough; Mucus; Nostrils get plugged; Hard to breath at Night; Mild pain on injection site; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Cholesterol and Enlarged prostate. Concomitant products included ATORVASTATIN for Hyperlipidemia, AMLODIPINE for Hypertension.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Mild pain on injection site). On 19-Mar-2021, the patient experienced SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night). On 10-Mar-2021, VACCINATION SITE PAIN (Mild pain on injection site) had resolved. At the time of the report, SNEEZING (Sneezes), COUGH (Cough), SECRETION DISCHARGE (Mucus), NASAL OBSTRUCTION (Nostrils get plugged) and DYSPNOEA (Hard to breath at Night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included two prostate medications. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Telephone contact report received on 28-JUN-2021:Contain non significant information
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site irritation
Clinical narrative: pain in the arm; redness in the arm; irritation at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (irritation at site of injection), PAIN IN EXTREMITY (pain in the arm) and ERYTHEMA (redness in the arm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced VACCINATION SITE IRRITATION (irritation at site of injection). On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm) and ERYTHEMA (redness in the arm). At the time of the report, VACCINATION SITE IRRITATION (irritation at site of injection), PAIN IN EXTREMITY (pain in the arm) and ERYTHEMA (redness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  She had irritation at the site of injection that went away. However, 8 days later it came back.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rhinorrhoea, Sneezing
Clinical narrative: Itchiness on head; Itchy neck; Itchy body; sneezing and runny nose; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included Melanoma (Had melanoma on the nose and had it removed two weeks ago).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose). At the time of the report, PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose) had resolved.            Concomitant product use was not provided by the reporter. Events sneezing and runny nose were present since 8 months.  Treatment includes allergy medications.  The patient stated that she had some health issues but it's not because of Moderna vaccine.  The action taken with mRNA-1273 with the events was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: TCR attached. The outcome was changed from  unknown to resolved.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Urinary tract infection
Clinical narrative: UTI; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI), MYALGIA (Body aches) and CHILLS (Chills) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). On 01-Apr-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI), MYALGIA (Body aches) and CHILLS (Chills) had resolved.            No relevant concomitant medications were reported.   No treatment information was provided.    Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received included event outcome
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Lymphadenopathy, Pain in extremity
Clinical narrative: Pain in left arm, collarbone; Pain in left arm, collarbone; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in left arm, collarbone), PAIN IN EXTREMITY (Pain in left arm, collarbone) and LYMPHADENOPATHY (Swollen lymph nodes) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (Pain in left arm, collarbone), PAIN IN EXTREMITY (Pain in left arm, collarbone) and LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, BONE PAIN (Pain in left arm, collarbone) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown and PAIN IN EXTREMITY (Pain in left arm, collarbone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Palpitations
Clinical narrative: racing heart; extreme heat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (racing heart) and FEELING HOT (extreme heat) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included LEVOTHYROXINE, CANDESARTAN, NIFEDIPINE, BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS RHAMNOSUS (PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]) and VITAMINS NOS for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PALPITATIONS (racing heart) and FEELING HOT (extreme heat). At the time of the report, PALPITATIONS (racing heart) and FEELING HOT (extreme heat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment was not reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Pain in extremity
Clinical narrative: Sore arm; Soreness in the lymph node area on left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and LYMPH NODE PAIN (Soreness in the lymph node area on left side) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and LYMPH NODE PAIN (Soreness in the lymph node area on left side). At the time of the report, PAIN IN EXTREMITY (Sore arm) and LYMPH NODE PAIN (Soreness in the lymph node area on left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.      This case was linked to MOD-2021-065886 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Headache, Lymph node pain, Pyrexia
Clinical narrative: swelling under left eye; fever; headache; soreness in the lymph node area on left side; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling under left eye), PYREXIA (fever), HEADACHE (headache) and LYMPH NODE PAIN (soreness in the lymph node area on left side) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced LYMPH NODE PAIN (soreness in the lymph node area on left side). On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE SWELLING (swelling under left eye), PYREXIA (fever) and HEADACHE (headache). At the time of the report, EYE SWELLING (swelling under left eye), PYREXIA (fever), HEADACHE (headache) and LYMPH NODE PAIN (soreness in the lymph node area on left side) outcome was unknown.            No relevant concomitant medication was reported. Treatment information was not provided.   This case was linked to MOD-2021-065885 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Pain, Pyrexia
Clinical narrative: experiencing brain fog from the first vaccine; achy; fatigue; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (experiencing brain fog from the first vaccine), PAIN (achy), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Coronary artery disease, Thrombus and Pneumonia.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (experiencing brain fog from the first vaccine), PAIN (achy), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills). At the time of the report, FEELING ABNORMAL (experiencing brain fog from the first vaccine), PAIN (achy), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Insomnia, Memory impairment, Pain
Clinical narrative: Dizzy; Can't Sleep; Forgetful; Very Tired; Soreness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), DIZZINESS (Dizzy), INSOMNIA (Can't Sleep), MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (In December 2020.) in December 2020.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (Soreness) and FATIGUE (Fatigue). On 17-Mar-2021, the patient experienced DIZZINESS (Dizzy), INSOMNIA (Can't Sleep), MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Very Tired). On 04-Mar-2021, PAIN (Soreness) and FATIGUE (Fatigue) had resolved. At the time of the report, DIZZINESS (Dizzy), INSOMNIA (Can't Sleep), MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Very Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever 102.8F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 102.8F) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 01-Apr-2021, the patient experienced PYREXIA (fever 102.8F). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever 102.8F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Body temperature: 102.8 (High) Fever 102.8F.         No relevant concomitant medication was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling of lymph node; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph node) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced LYMPHADENOPATHY (Swelling of lymph node). At the time of the report, LYMPHADENOPATHY (Swelling of lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Under recommended age; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under recommended age) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder (multiple autoimmune diseases), Rheumatoid arthritis, Cystic fibrosis and Wheelchair user.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under recommended age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under recommended age) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up received on 30-JUN-2021.Added patient race and vaccination address.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Intermenstrual bleeding, Muscle spasms, Paraesthesia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingly on both arms and left side of face), PARAESTHESIA (Right hand is still tingling), DIARRHOEA (Diarrhea x 2 episodes), MUSCLE SPASMS (Cramps) and INTERMENSTRUAL BLEEDING (Spotting (Period not due and Not Pregnant)) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  No Medical History information was reported. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PARAESTHESIA (Tingly on both arms and left side of face). On 31-Mar-2021, the patient experienced DIARRHEA (Diarrhea x 2 episodes), MUSCLE SPASMS (Cramps) and HEADACHE (Headache). On 01-Apr-2021, the patient experienced PARAESTHESIA (Right hand is still tingling) and INTERMENSTRUAL BLEEDING (Spotting (Period not due and Not Pregnant)). On 01-Apr-2021, PARAESTHESIA (Tingly on both arms and left side of face) had resolved. At the time of the report, PARAESTHESIA (Right hand is still tingling), DIARRHEA (Diarrhea x 2 episodes), MUSCLE SPASMS (Cramps), INTERMENSTRUAL BLEEDING (Spotting (Period not due and Not Pregnant)) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medication was reported. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: itchy; red giant round area the size of a mosquito bite measuring 4 inches long by 3 inches wide; some soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red giant round area the size of a mosquito bite measuring 4 inches long by 3 inches wide) and VACCINATION SITE PAIN (some soreness at site of injection) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (some soreness at site of injection). On 18-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red giant round area the size of a mosquito bite measuring 4 inches long by 3 inches wide). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 10-Mar-2021, VACCINATION SITE PAIN (some soreness at site of injection) had resolved. On 20-Mar-2021, VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red giant round area the size of a mosquito bite measuring 4 inches long by 3 inches wide) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), PYREXIA (102F fever), CHILLS (some chills) and MYALGIA (some aches) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Surgery. Concurrent medical conditions included Diabetes. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced HYPERHIDROSIS (sweats), PYREXIA (102F fever), CHILLS (some chills) and MYALGIA (some aches). At the time of the report, HYPERHIDROSIS (sweats), PYREXIA (102F fever), CHILLS (some chills) and MYALGIA (some aches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. The concomitant medication was not provided. The treatment information was not provided. This case was linked to MOD-2021-066693.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue
Clinical narrative: diarrhea; joint pain; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FATIGUE (feeling tired) and ARTHRALGIA (joint pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included POTASSIUM, METOPROLOL and LOSARTAN for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced FATIGUE (feeling tired). On 31-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and ARTHRALGIA (joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Mar-2021, FATIGUE (feeling tired) had resolved. On 31-Mar-2021, DIARRHOEA (diarrhea) and ARTHRALGIA (joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also includes, lupus pill, thyroid pill, water pills and thyroid medication.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Arthralgia, Disorientation, Headache, Muscle spasms
Clinical narrative: could not move left hand; swelling of tongue, could not speak; swelling of tongue, could not speak; disoriented; Neck and shoulder pain; headache; Neck and shoulder pain; I was in lots of pain; Red welt on injection site; Muscle weakness; Swelling of face; Cramps in legs; Irritation; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented) and NECK PAIN (Neck and shoulder pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation). On 27-Mar-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-may-2021 and contain non significant information
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia, Neck pain, Skin irritation, Swelling face
Clinical narrative: could not move left hand; swelling of tongue, could not speak; swelling of tongue, could not speak; disoriented; Neck and shoulder pain; headache; Neck and shoulder pain; I was in lots of pain; Red welt on injection site; Muscle weakness; Swelling of face; Cramps in legs; Irritation; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented) and NECK PAIN (Neck and shoulder pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation). On 27-Mar-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-may-2021 and contain non significant information
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Vaccination site movement impairment, Vaccination site urticaria
Clinical narrative: could not move left hand; swelling of tongue, could not speak; swelling of tongue, could not speak; disoriented; Neck and shoulder pain; headache; Neck and shoulder pain; I was in lots of pain; Red welt on injection site; Muscle weakness; Swelling of face; Cramps in legs; Irritation; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented) and NECK PAIN (Neck and shoulder pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation). On 27-Mar-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-may-2021 and contain non significant information
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: I had a horrific, all of a sudden it felt like the top of my head was going to blow off; arm started swelling and hurting; arm started swelling and hurting; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (I had a horrific, all of a sudden it felt like the top of my head was going to blow off), PERIPHERAL SWELLING (arm started swelling and hurting) and PAIN IN EXTREMITY (arm started swelling and hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (I had a horrific, all of a sudden it felt like the top of my head was going to blow off), PERIPHERAL SWELLING (arm started swelling and hurting) and PAIN IN EXTREMITY (arm started swelling and hurting). At the time of the report, HEAD DISCOMFORT (I had a horrific, all of a sudden it felt like the top of my head was going to blow off) and PAIN IN EXTREMITY (arm started swelling and hurting) outcome was unknown and PERIPHERAL SWELLING (arm started swelling and hurting) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.    Treatment included as Baking soda in water.